2025-07-29 Drugs SFDA Approves the Registration of “Leqembi” as the First Alzheimer’s Treatment in Saudi Arabia
2025-07-23 Drugs SFDA Announces Registration of “Skyclarys” for the Treatment of a Rare Genetic Neurological Disorder
